Crux is a registered and licensed South African pharmaceutical company established in 2007.
South Africa is an incredibly attractive investment destination for pharmaceutical companies and even more so now with National Health Care on the horizon.
Since 1994, South Africa has brought in revised regulations and procedures for the pharmaceutical industry and created a highly regulated environment. The regulatory environment has evolved significantly with the introduction of international partnerships and initiatives, therefore the administrative and regulatory aspects of doing business in South Africa have become significantly more complex.
We provide an end-to-end solution, from developing a business plan to a fully established company for our clients.
Our costs are economical, and the client’s expenses and timelines are considerably reduced by partnering with us to launch their products in South Africa or by engaging us as an advisor.
In this way, the partner or client has the benefit of testing the market before making an investment in human resources, bricks and mortar or committing to a strategy.
Some of the companies that we have worked with or are working with are: AIM (US), Herbal Solutions (SA), Serum Institute of India (India), 4 Life, Cipla, Orthomol (Germany), Biocon, Accord.
There are also considerable growth opportunities in the rest of Africa that we can assist you with. South Africa is also a launching pad into the rest of Africa.
Our clients can tap into our in-depth knowledge of the South African landscape.
One of our primary strengths is our expertise on how to effectively invest in South Africa. Our thorough understanding of the pharmaco-legal requirements is the reason why our partners like working with us for the registration of their products and the development of their business.
We invite you to touch base with us and find out how we can help your business.